Skip to main content
. 2023 Aug 7;10:1194605. doi: 10.3389/fcvm.2023.1194605

Figure 3.

Figure 3

Pooled relative risks and 95% confidence intervals for MACE and the individual components and adverse events in the colchicine and control groups. (A) Major adverse cardiovascular events (MACE); (B) Myocardial infarction (MI); (C) Unstable angina (UA); (D) Stroke; (E) All-cause death; (F) Heart failure; (G) Left ventricular ejection fraction (LVEF); (H) Diarrhea; (I) Gastrointestinal adverse events.